Literature DB >> 18774283

Social and structural aspects of the overdose risk environment in St. Petersburg, Russia.

Traci C Green1, Lauretta E Grau, Ksenia N Blinnikova, Mikhail Torban, Evgeny Krupitsky, Ruslan Ilyuk, Andrei Kozlov, Robert Heimer.   

Abstract

BACKGROUND: While overdose is a common cause of mortality among opioid injectors worldwide, little information exists on opioid overdoses or how context may influence overdose risk in Russia. This study sought to uncover social and structural aspects contributing to fatal overdose risk in St. Petersburg and assess prevention intervention feasibility.
METHODS: Twenty-one key informant interviews were conducted with drug users, treatment providers, toxicologists, police, and ambulance staff. Thematic coding of interview content was conducted to elucidate elements of the overdose risk environment.
RESULTS: Several factors within St. Petersburg's environment were identified as shaping illicit drug users' risk behaviours and contributing to conditions of suboptimal response to overdose in the community. Most drug users live and experience overdoses at home, where family and home environment may mediate or moderate risk behaviours. The overdose risk environment is also worsened by inefficient emergency response infrastructure, insufficient cardiopulmonary or naloxone training resources, and the preponderance of abstinence-based treatment approaches to the exclusion of other treatment modalities. However, attitudes of drug users and law enforcement officials generally support overdose prevention intervention feasibility. Modifiable aspects of the risk environment suggest community-based and structural interventions, including overdose response training for drug users and professionals that encompasses naloxone distribution to the users and equipping more ambulances with naloxone.
CONCLUSION: Local social and structural elements influence risk environments for overdose. Interventions at the community and structural levels to prevent and respond to opioid overdoses are needed for and integral to reducing overdose mortality in St. Petersburg.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774283      PMCID: PMC2696401          DOI: 10.1016/j.drugpo.2008.07.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  39 in total

1.  Role of the family in drug abuse.

Authors:  S K Kartikeyan; R M Chaturvedi; V R Bhalerao
Journal:  J Postgrad Med       Date:  1992 Jan-Mar       Impact factor: 1.476

2.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

3.  Drug use settings: an emerging focus for research and intervention.

Authors:  Thomas Kerr; Jo Kimber; Tim Rhodes
Journal:  Int J Drug Policy       Date:  2007-02-01

4.  Relation of parental support and control to adolescents' externalizing symptomatology and substance use: a longitudinal examination of curvilinear effects.

Authors:  E Stice; M Barrera; L Chassin
Journal:  J Abnorm Child Psychol       Date:  1993-12

5.  Non-fatal overdose and subsequent drug treatment among injection drug users.

Authors:  Robin A Pollini; Lisa McCall; Shruti H Mehta; David Vlahov; Steffanie A Strathdee
Journal:  Drug Alcohol Depend       Date:  2005-11-23       Impact factor: 4.492

6.  HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia.

Authors:  Alla V Shaboltas; Olga V Toussova; Irving F Hoffman; Robert Heimer; Sergei V Verevochkin; Robert W Ryder; Kaveh Khoshnood; Tom Perdue; Benoit R Masse; Andrei P Kozlov
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-15       Impact factor: 3.731

7.  Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.

Authors:  Traci C Green; Robert Heimer; Lauretta E Grau
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

8.  When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors.

Authors:  Paul Dietze; Damien Jolley; Craig L Fry; Gabriele Bammer; David Moore
Journal:  Drug Alcohol Depend       Date:  2006-03-20       Impact factor: 4.492

9.  Naltrexone for heroin dependence treatment in St. Petersburg, Russia.

Authors:  Evgeny M Krupitsky; Edwin E Zvartau; Dimitry V Masalov; Marina V Tsoi; Andrey M Burakov; Valentina Y Egorova; Tatyana Y Didenko; Tatyana N Romanova; Eva B Ivanova; Anton Y Bespalov; Elena V Verbitskaya; Nikolai G Neznanov; Alexandr Y Grinenko; Charles P O'Brien; George E Woody
Journal:  J Subst Abuse Treat       Date:  2004-06

10.  A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.

Authors:  Thomas Kerr; Will Small; David Moore; Evan Wood
Journal:  Int J Drug Policy       Date:  2007-01-16
View more
  16 in total

1.  Law enforcement attitudes toward overdose prevention and response.

Authors:  Traci C Green; Nickolas Zaller; Wilson R Palacios; Sarah E Bowman; Madeline Ray; Robert Heimer; Patricia Case
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

Review 2.  HIV infection and risk of overdose: a systematic review and meta-analysis.

Authors:  Traci C Green; Samuel K McGowan; Michael A Yokell; Enrique R Pouget; Josiah D Rich
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

3.  Take-home naloxone possession among people who inject drugs in rural West Virginia.

Authors:  Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Suzanne M Grieb; Michael E Kilkenny; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2019-09-21       Impact factor: 4.492

4.  A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Eur J Epidemiol       Date:  2017-12-12       Impact factor: 8.082

5.  Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs.

Authors:  Alexander Y Walley; Debbie M Cheng; Sharon M Coleman; Evgeny Krupitsky; Anita Raj; Elena Blokhina; Carly Bridden; Christine E Chaisson; Marlene C Lira; Jeffrey H Samet
Journal:  AIDS Care       Date:  2014-01-02

Review 6.  Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: the need for a syndemic approach.

Authors:  Louisa Gilbert; Sholpan Primbetova; Danil Nikitin; Timothy Hunt; Assel Terlikbayeva; Azzi Momenghalibaf; Murodali Ruziev; Nabila El-Bassel
Journal:  Drug Alcohol Depend       Date:  2013-08-13       Impact factor: 4.492

7.  Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs.

Authors:  Alexander Y Walley; Debbie M Cheng; Emily K Quinn; Elena Blokhina; Natalia Gnatienko; Christine E Chaisson; Evgeny Krupitsky; Philip O Coffin; Jeffrey H Samet
Journal:  Int J Drug Policy       Date:  2016-11-28

8.  High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.

Authors:  Alexander R Bazazi; Alexei Zelenev; Jeannia J Fu; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2014-12-02

9.  Commentary on Sacks-Davis et al. (2016): Quantifying the risk environment-effect modification and precision population health.

Authors:  Geetanjoli Banerjee; Brandon D L Marshall
Journal:  Addiction       Date:  2016-11       Impact factor: 6.526

10.  Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia.

Authors:  Lauretta E Grau; Traci C Green; Mikhail Torban; Ksenia Blinnikova; Evgeny Krupitsky; Ruslan Ilyuk; Andrei P Kozlov; Robert Heimer
Journal:  Harm Reduct J       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.